The Recall Desk
SevereFDA (Drugs)·D-1261-2014·Announced 2014-04-30

Hospira Recalls Potassium Chloride Vials Due to Particulate Matter

Hospira is recalling 255,900 vials of Potassium Chloride for Injection due to the presence of red and black particulate matter identified as iron oxide.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class II, which corresponds to a 'Severe' rating (score 4) under the rubric, particularly given the presence of foreign particulate matter in an injectable medication.

Plain-English summary

Hospira Inc. is voluntarily recalling 255,900 vials of Potassium Chloride for Injection Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial. The recall was initiated because red and black particulate matter was identified within the solution and embedded within the plastic vial. The particulate has been identified as iron oxide.

The affected product is Lot 22-127-DK, which was distributed nationwide. The product is a prescription-only medication intended for intravenous use. No specific dates of distribution or specific facilities affected are listed in the source text.

Healthcare providers and patients should stop using the affected product and contact Hospira Inc. for further instructions or a replacement. Consumers should not attempt to use the recalled vials.

The recalled product

Product
Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA
Manufacturer
Hospira Inc.
Affected units
255,900

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot 22-127-DK

Distribution

Distributed nationwide across the United States.